The hunt for nutritional and pharmacological modulators of paraoxonase

被引：43

作者：

Durrington, PN ^{[1
]}

Mackness, B ^{[1
]}

Mackness, MI ^{[1
]}

机构：

[1] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2002年 / 22卷 / 08期

关键词：

D O I：

10.1161/01.ATV.0000027414.34728.1F

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1248 / 1250

页数：3

共 43 条

[1] Vitamin E supplementation increases the resistance of both LDL and HDL, to oxidation and increases cholesteryl ester transfer activity [J].

Arrol, S ;

Mackness, MI ;

Durrington, PN .

ATHEROSCLEROSIS, 2000, 150 (01) :129-134

[2] Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions - PON1 esterase and peroxidase-like activities [J].

Aviram, M ;

Hardak, E ;

Vaya, J ;

Mahmood, S ;

Milo, S ;

Hoffman, A ;

Billicke, S ;

Draganov, D ;

Rosenblat, M .

CIRCULATION, 2000, 101 (21) :2510-2517

[3] Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants [J].

Aviram, M ;

Rosenblat, M ;

Billecke, S ;

Erogul, J ;

Sorenson, R ;

Bisgaier, CL ;

Newton, RS ;

La Du, B .

FREE RADICAL BIOLOGY AND MEDICINE, 1999, 26 (7-8) :892-904

[4] Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation [J].

Aviram, M ;

Rosenblat, M ;

Bisgaier, CL ;

Newton, RS .

ATHEROSCLEROSIS, 1998, 138 (02) :271-280

[5]

Aviram M, 2000, AM J CLIN NUTR, V71, P1062

[6] Effects of simvastatin on serum paraoxonase activity [J].

Balogh, Z ;

Fülöp, P ;

Seres, I ;

Harangi, M ;

Katona, E ;

Kovacs, P ;

Kosztáczky, B ;

Paragh, G .

CLINICAL DRUG INVESTIGATION, 2001, 21 (07) :505-510

[7] CETP and atherosclerosis [J].

Barter, P .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (09) :2029-2031

[8] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[9] Paraoxonase and atherosclerosis [J].

Durrington, PN ;

Mackness, B ;

Mackness, MI .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) :473-480

[10] Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia [J].

Durrington, PN ;

Mackness, MI ;

Bhatnagar, D ;

Julier, K ;

Prais, H ;

Arrol, S ;

Morgan, J ;

Wood, GNI .

ATHEROSCLEROSIS, 1998, 138 (01) :217-225

← 1 2 3 4 5 →